VERTEX PHARMACEUTICALS INC / MA — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| LEIDEN JEFFREY M | Executive Chairman | Sale | 4,352 | $444.36 | $1,933,855 | Dec 4, 2025 |
| WAGNER CHARLES F JR | EVP, CO & FO | Sale | 7,000 | $461.00 | $3,227,000 | Dec 3, 2025 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sale | 4,500 | $449.99 | $2,024,955 | Dec 3, 2025 |
| Biller Jonathan | EVP and Chief Legal Officer | Sale | 347 | $449.00 | $155,803 | Dec 3, 2025 |
| CARNEY LLOYD | — | Gift | 800 | — | — | Nov 19, 2025 |
| Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sale | 2,500 | $434.58 | $1,086,450 | Nov 17, 2025 |
| LEIDEN JEFFREY M | Executive Chairman | Option Exercise | 13,835 | $91.05 | $1,259,677 | Nov 13, 2025 |
| Biller Jonathan | EVP and Chief Legal Officer | Tax Withholding | 1,259 | $400.00 | $503,600 | Oct 2, 2025 |
| Bhatia Sangeeta N. | — | Sale | 266 | $386.69 | $102,860 | Aug 27, 2025 |
| Kewalramani Reshma | CEO & President | Purchase | 5,710 | $389.95 | $2,226,615 | Aug 6, 2025 |
| SACHS BRUCE I | — | Purchase | 3,366 | $389.84 | $1,312,201 | Aug 6, 2025 |
| Arbuckle Stuart A | EVP, COO | Tax Withholding | 37,243 | $450.23 | $16,767,916 | Jul 1, 2025 |
| ALTSHULER DAVID | EVP, Chief Scientific Officer | Sale | 52 | $424.69 | $22,084 | May 15, 2025 |
| Arbuckle Stuart A | EVP, COO | Award / Grant | 37,622 | — | — | May 13, 2025 |
| Upadhyay Suketu | — | Disposition | 1,001 | — | — | May 1, 2025 |
| Thornberry Nancy | — | Award / Grant | 398 | — | — | May 1, 2025 |
| Schneider Jennifer | — | Award / Grant | 796 | — | — | May 1, 2025 |
| MCKENZIE DIANA | — | Disposition | 1,001 | — | — | May 1, 2025 |
| Garber Alan M | — | Award / Grant | 398 | — | — | May 1, 2025 |
| CARNEY LLOYD | — | Award / Grant | 796 | — | — | May 1, 2025 |
| Bhatia Sangeeta N. | — | Sale | 400 | $505.86 | $202,344 | May 1, 2025 |
| ALTSHULER DAVID | EVP, Chief Scientific Officer | Sale | 3,231 | $510.00 | $1,647,810 | Mar 13, 2025 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sale | 3,298 | $500.00 | $1,649,000 | Mar 10, 2025 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sale | 3,242 | $499.99 | $1,620,968 | Mar 10, 2025 |
| ALTSHULER DAVID | EVP, Chief Scientific Officer | Sale | 3,231 | $500.00 | $1,615,500 | Mar 10, 2025 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sale | 4,058 | $485.49 | $1,970,118 | Mar 4, 2025 |
| ALTSHULER DAVID | EVP, Chief Scientific Officer | Sale | 3,231 | $490.00 | $1,583,190 | Mar 3, 2025 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | Tax Withholding | 4,962 | $479.61 | $2,379,825 | Feb 26, 2025 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sale | 530 | $475.34 | $251,930 | Feb 26, 2025 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Tax Withholding | 3,703 | $479.61 | $1,775,996 | Feb 26, 2025 |
| Kewalramani Reshma | CEO & President | Tax Withholding | 14,079 | $479.61 | $6,752,429 | Feb 26, 2025 |
| Bozic Carmen | EVP and CMO | Tax Withholding | 4,962 | $479.61 | $2,379,825 | Feb 26, 2025 |
| Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sale | 2,650 | $475.34 | $1,259,651 | Feb 26, 2025 |
| Arbuckle Stuart A | EVP, COO | Tax Withholding | 7,071 | $479.61 | $3,391,322 | Feb 26, 2025 |
| Ambrose Kristen | SVP & Chief Accounting Officer | Tax Withholding | 1,241 | $479.61 | $595,196 | Feb 26, 2025 |
| ALTSHULER DAVID | EVP, Chief Scientific Officer | Sale | 1,272 | $480.00 | $610,560 | Feb 26, 2025 |
| Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Tax Withholding | 1,656 | $483.28 | $800,312 | Feb 25, 2025 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | Tax Withholding | 3,310 | $483.28 | $1,599,657 | Feb 24, 2025 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sale | 354 | $480.95 | $170,256 | Feb 24, 2025 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Tax Withholding | 2,470 | $483.28 | $1,193,702 | Feb 24, 2025 |
| Kewalramani Reshma | CEO & President | Tax Withholding | 9,386 | $483.28 | $4,536,066 | Feb 24, 2025 |
| Bozic Carmen | EVP and CMO | Tax Withholding | 3,310 | $483.28 | $1,599,657 | Feb 24, 2025 |
| Arbuckle Stuart A | EVP, COO | Tax Withholding | 4,716 | $483.28 | $2,279,148 | Feb 24, 2025 |
| Ambrose Kristen | SVP & Chief Accounting Officer | Sale | 884 | $480.95 | $425,160 | Feb 24, 2025 |
| ALTSHULER DAVID | EVP, Chief Scientific Officer | Sale | 848 | $480.95 | $407,846 | Feb 24, 2025 |
| ALTSHULER DAVID | EVP, Chief Scientific Officer | Sale | 1,111 | $480.00 | $533,280 | Feb 20, 2025 |
| Biller Jonathan | EVP and Chief Legal Officer | Tax Withholding | 1,504 | $463.46 | $697,044 | Feb 18, 2025 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | Tax Withholding | 2,293 | $463.46 | $1,062,714 | Feb 14, 2025 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sale | 244 | $455.06 | $111,035 | Feb 14, 2025 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Tax Withholding | 2,139 | $463.46 | $991,341 | Feb 14, 2025 |